Pressure-derived collateral flow index as a parameter of microvascular dysfunction in acute myocardial infarction

J Am Coll Cardiol. 2001 Nov 1;38(5):1383-9. doi: 10.1016/s0735-1097(01)01585-6.

Abstract

Objectives: The goal of this study was to examine the implications of the pressure-derived collateral flow index (CFIp) in acute myocardial infarction (AMI).

Background: Higher CFIp is associated with less severe myocardial ischemia during angioplasty in the non-infarcted heart. It remains unknown whether CFIp also identifies collateral function in AMI patients with and without no-reflow phenomenon.

Methods: The study population included 48 patients with a first AMI. After successful percutaneous transluminal coronary angioplasty (PTCA) stent, we measured mean aortic pressure (Pa), central venous pressure (Pv) and coronary wedge pressure (Pcw) of the infarct-related artery to calculate: CFIp = (Pcw - Pv)/(Pa - Pv). Myocardial contrast echocardiography (MCE) was performed with the intracoronary injection of microbubbles to assess myocardial perfusion. Left ventriculograms at days 1 and 28 were provided for the measurement of the regional wall motion (RWM, SD/chord).

Results: There was no difference in CFIp among subsets based on angiographic collateral grades (grade 0, 1, 2, 3; 0.28 +/- 0.07, 0.27 +/- 0.09, 0.27 +/- 0.08, 0.23 +/- 0.08, p = NS). The CFIp was significantly higher in patients with MCE no-reflow (n = 16) than in those with MCE reflow (n = 32) (0.34 +/- 0.07 vs. 0.23 +/- 0.06, p < 0.01). There was a significant inverse correlation between the extent of functional improvement (DeltaRWM[28 d-1 d]) and CFIp (r = 0.56, p < 0.01), implying that higher CFIp is associated with worse functional improvement.

Conclusions: In AMI, CFIp is unlikely to reflect collateral function but seems to increase with the severity of microvascular dysfunction. Because higher CFIp was associated with poorer functional recovery, it provides a simple and useful estimate of clinical outcomes in AMI.

Publication types

  • Validation Study

MeSH terms

  • Aged
  • Analysis of Variance
  • Angioplasty, Balloon, Coronary
  • Blood Flow Velocity*
  • Blood Pressure*
  • Central Venous Pressure*
  • Collateral Circulation*
  • Coronary Angiography
  • Coronary Circulation*
  • Echocardiography
  • Female
  • Fibrinolytic Agents / therapeutic use
  • Humans
  • Male
  • Microcirculation*
  • Middle Aged
  • Myocardial Infarction / classification*
  • Myocardial Infarction / diagnosis
  • Myocardial Infarction / physiopathology*
  • Myocardial Infarction / therapy
  • Predictive Value of Tests
  • Prognosis
  • Prospective Studies
  • Pulmonary Wedge Pressure*
  • Recovery of Function
  • Severity of Illness Index*
  • Time Factors
  • Treatment Outcome
  • Vascular Patency

Substances

  • Fibrinolytic Agents